Skip to content

Chronic Pain and Hemophilia

Status of Chronic Pain in Patients With Hemophilia.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05202951
Acronym
HEMODOL
Enrollment
350
Registered
2022-01-24
Start date
2022-02-28
Completion date
2026-09-01
Last updated
2026-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Hemophilia

Keywords

Chronic Pain, Hemophilia

Brief summary

Hemophilia (A and B) are X-linked hereditary bleeding disorders whose severity depends on the level of coagulation factor (FVIII or FIX respectively). Bleeding is mainly from joints (hemarthrosis) and muscles (hematoma). Nowadays, treatment is based on preventive or curative intravenous infusion of coagulation factor concentrates. Despite these treatments, there is joint deterioration that can be responsible for hemophilic arthropathy and chronic pain. This pain may be related to excess nociception during acute bleeding, but it may also be neuropathic. There are only a few studies that have looked at pain in hemophilia, but it is accepted that the vast majority of patients (especially those with severe forms) suffer from chronic pain. Because patients have become accustomed to this pain and physicians are still not very aware of how to assess it, this pain is not treated effectively. In order to better manage pain in hemophilia, it is therefore necessary to characterize their pain and to know the nociceptive or neuropathic component. The aim of our study is therefore to study the prevalence, the nociceptive or neuropathic profile, the chronic aspect of pain and the main locations of pain in hemophilia. In addition to raising the awareness of physicians in the centers about pain management using specific questionnaires, this survey will help to better define chronic pain in hemophilia of all severities.

Detailed description

This first French assessment of chronic pain in patients with haemophilia will permit to improve and generate new data about chronic pain related to haemophilia, associated-comorbidities, sociodemographic characteristics and analgesic treatments used. These data will be retrieved using several questionnaires in the RedCap web plateform (eCRF). The study will include 6 investigator centres and a minimum of 350 patients during 12 months.

Interventions

OTHERquestionnaires

Electronic case report form integrating questionnaires on chronic pain related to haemophilia, associated-comorbidities, sociodemographic characteristics and analgesic treatments used.

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with haemophilia of any severity, * Carrier female with low levels haemophilia (\< 40%), * ≥ 18 years of age and capable of giving informed consent to participate in research.

Exclusion criteria

* Patient's refusal to participate in the survey, * Patient does not understand enough French (written and spoken) to complete the survey, * Patient unable to complete the survey for logistical reasons (lack of internet access), * Patient under protective measures (guardianship), * Patients with known addictive comorbidities and/or cognitive disorders.

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of chronic pain disordersthrough study completion, an average of 1 yearQuestionnaire "Brief Pain Inventory" (BPI) + History of chronic pain (≥ 3 months, Yes or No)

Secondary

MeasureTime frameDescription
Impact of chronic pain in daily lifethrough study completion, an average of 1 yearSpecific questions + Western Ontario and McMaster University Osteoarthritis (WOMAC)
Analgesic consumptionthrough study completion, an average of 1 yearType and quantity of analgesic used for treating chronic pain
Anxiodepressive disordersthrough study completion, an average of 1 yearHospital Anxiety and Depression scale (HADS): this questionnaire makes it possible to detect anxiety and depressive disorders. It has 14 items sided from 0 to 3. Seven questions relate to anxiety and the 7 to the depressive dimension, thus obtaining two scores of up to 21.
Sleep disordersthrough study completion, an average of 1 yearMOS-Sleep scale (MOS-SS) questionnaire: this questionnaire deals with daytime sleepiness. It also looks at a person's ability to stay and fall asleep, how often they sleep and for how long, whether the sleep they get is adequate for their lifestyle, and any existing breathing factors that can affect sleep like sleep apnea.
Perceived injustice of chronic painthrough study completion, an average of 1 yearInjustice Experience Questionnaire (IEQ)

Countries

France

Contacts

PRINCIPAL_INVESTIGATORAurélien LEBRETON

University Hospital, Clermont-Ferrand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 30, 2026